| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2 |
| P698 | PubMed publication ID | 9920013 |
| P50 | author | W. Michael O'Fallon | Q102207830 |
| P2093 | author name string | Gabriel SE | |
| Thumboo J | |||
| Sunku J | |||
| Michet CJ Jr | |||
| Uramoto KM | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Changes in clinical features of patients with systemic lupus erythematosus followed prospectively over 2 decades | Q33191755 | ||
| History of the Rochester Epidemiology Project | Q34374377 | ||
| Incidence of systemic lupus erythematosus. Race and gender differences | Q40422635 | ||
| Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus | Q40593753 | ||
| Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. | Q41072119 | ||
| Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes | Q43970492 | ||
| Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. | Q50578776 | ||
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| lupus erythematosus | Q188297 | ||
| P304 | page(s) | 46-50 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. | |
| P478 | volume | 42 |
| Q46080033 | 46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study |
| Q33868909 | A clinico-pathological study of lupus nephritis based on the International Society of Nephrology-Renal Pathology Society 2003 classification system |
| Q43772908 | A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus |
| Q50146708 | Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: a study with a questionnaire |
| Q89136004 | Age-adjusted Charlson Comorbidity Index scores predict major adverse cardiovascular events and all-cause mortality among systemic lupus erythematosus patients |
| Q50543553 | Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. |
| Q38983818 | Anthrax Vaccine and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus in the U.S. Military: A Case-Control Study |
| Q91972788 | Anti-CD22 epratuzumab for systemic lupus erythematosus: A systematic review and meta-analysis of randomized controlled trials |
| Q37541229 | Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study |
| Q51417247 | Antinuclear antibody positive autoimmune disorders in North India: an appraisal. |
| Q44277701 | Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study. |
| Q33557464 | Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. |
| Q53270426 | Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors. |
| Q46042196 | Burden of systemic lupus erythematosus in Taiwan: a population-based survey. |
| Q40754916 | Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. |
| Q43885994 | Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study |
| Q90391852 | Changing trends in mortality in systemic lupus erythematosus? An analysis of SLE inpatient mortality at University Hospital Coventry and Warwickshire NHS Trust from 2007 to 2016 |
| Q39067278 | Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. |
| Q37127464 | Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus |
| Q38133017 | Clinical aspects of autoimmune rheumatic diseases |
| Q38618968 | Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study |
| Q46956410 | Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization |
| Q41540102 | Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis |
| Q36632600 | Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies |
| Q37118987 | Cytokines and their receptors as biomarkers of systemic lupus erythematosus. |
| Q43772904 | Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus |
| Q46810854 | Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis. |
| Q38649232 | Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis |
| Q26749296 | Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools |
| Q87065756 | Diagnostic criteria for systemic lupus erythematosus: has the time come? |
| Q37413878 | Disparities in lupus care and outcomes |
| Q37381187 | Dominant Th1 and minimal Th17 skewing in discoid lupus revealed by transcriptomic comparison with psoriasis |
| Q41012612 | EBV-Associated Cancer and Autoimmunity: Searching for Therapies. |
| Q35554126 | EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis |
| Q44102075 | Editorial: Updates in US systemic lupus erythematosus epidemiology: Tales of two cities |
| Q34986307 | Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. |
| Q37069392 | Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004 |
| Q35567251 | Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States |
| Q37800292 | Epidemiology of systemic lupus erythematosus in Asia |
| Q53839415 | Epidemiology of systemic lupus erythematosus. |
| Q40065685 | Epidemiology of systemic lupus erythematosus: capturing the butterfly. |
| Q39560849 | Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). |
| Q37162898 | Ethnic disparities among patients with systemic lupus erythematosus in South Carolina |
| Q35638060 | Ethnicity and mortality from systemic lupus erythematosus in the US. |
| Q36466879 | Evaluation of brain and cervical MRI abnormality rates in patients with systemic lupus erythematosus with or without neurological manifestations |
| Q35088861 | Exposure to maternal smoking and incident SLE in a prospective cohort study |
| Q34824708 | Factors that determine body composition of female systemic lupus erythematosus (SLE) patients in Sri Lanka: a comparative study using dual-energy x-ray absorptiometry |
| Q34108932 | Familial autoimmunity and the idiopathic inflammatory myopathies |
| Q36237845 | Gender differences in systemic lupus erythematosus |
| Q33893349 | Genetics of systemic lupus erythematosus. Clinical implications |
| Q36849928 | Genome-wide association study identified the human leukocyte antigen region as a novel locus for plasma beta-2 microglobulin |
| Q46234526 | Geographical variation in mortality from systemic lupus erythematosus in the United States |
| Q37762438 | Glomerular disease: why is there a dearth of high quality clinical trials? |
| Q44089331 | Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres. |
| Q73683618 | Hopkins Lupus Cohort. 1999 update |
| Q40039972 | Hormonal contraception and the development of autoimmunity: A review of the literature |
| Q33533703 | Identification and validation of lupus nephritis cases using administrative data |
| Q36301524 | IgG and IgM autoantibody differences in discoid and systemic lupus patients |
| Q64955185 | Immunologic findings precede rapid lupus flare after transient steroid therapy. |
| Q50041259 | Immunological Rare Diseases |
| Q35552600 | Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment |
| Q79339706 | Improving survival in inflammatory rheumatic diseases: a neglected goal? |
| Q90133680 | In-hospital mortality in patients with systemic lupus erythematosus: a study from Jordan 2002-2017 |
| Q46603420 | Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population |
| Q34424638 | Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study |
| Q36422028 | Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. |
| Q51151220 | Incidence and prognosis of systemic lupus erythematosus in a 35 year period in Fukushima, Japan. |
| Q37636312 | Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study |
| Q40672396 | Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria |
| Q38858579 | Influence of Alcohol Consumption on the Risk of Systemic Lupus Erythematosus Among Women in the Nurses' Health Study Cohorts |
| Q38095888 | Is there a cure for systemic lupus erythematosus? |
| Q38227479 | Is there still a role for abatacept in the treatment of lupus? |
| Q39053147 | It hasn't gone away: the problem of glucocorticoid use in lupus remains. |
| Q36787315 | LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus |
| Q40501964 | Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus |
| Q37653013 | Lifetime incidence risk of alopecia areata estimated at 2.1% by Rochester Epidemiology Project, 1990-2009. |
| Q38659241 | Lupus erythematosus revisited. |
| Q34638296 | Lupus: an overview of the disease and management options |
| Q35060268 | Modern obstetrical and infertility care may increase the prevalence of disease: an evolutionary concept |
| Q37684625 | Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort |
| Q46665204 | Mortality and causes of death among incident cases of systemic lupus erythematosus in Finland 2000-2008. |
| Q46313788 | Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis |
| Q52726621 | Mycophenolic acid induces senescence of vascular precursor cells. |
| Q35729264 | Nasal manifestations of systemic illnesses |
| Q38800560 | Nasal surgery in patients with systemic disorders |
| Q51148648 | Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. |
| Q37463463 | Natural genetic variation profoundly regulates gene expression in immune cells and dictates susceptibility to CNS autoimmunity. |
| Q36440223 | Neuropsychiatric features of a cohort of patients with systemic lupus erythematosus |
| Q28193487 | New therapies and preventive strategies to treat and minimize damage in lupus |
| Q40253467 | Novel insights into systemic autoimmune rheumatic diseases using shared molecular signatures and an integrative analysis |
| Q38436812 | Ocular manifestations in systemic lupus erythematosus |
| Q30409882 | Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosus |
| Q46676587 | Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients |
| Q34192060 | Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators |
| Q24811541 | Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study |
| Q35551526 | Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades |
| Q43861291 | Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. |
| Q40817900 | Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis |
| Q81453725 | Persistence of unmet need for care among people with systemic lupus erythematosus: a longitudinal study |
| Q40103423 | Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study |
| Q40710206 | Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012. |
| Q90190679 | Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia |
| Q54063048 | Pregnancy outcome in women with pre-existing lupus nephritis. |
| Q51601971 | Premature coronary artery calcification is associated with disease duration and bone mineral density in young female systemic lupus erythematosus patients. |
| Q37777642 | Prevalence and burden of pediatric-onset systemic lupus erythematosus |
| Q38423234 | Prevalence and incidence of systemic lupus erythematosus in South Korea |
| Q37334183 | Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies |
| Q31113801 | Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data |
| Q51597128 | Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. |
| Q40374986 | Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus |
| Q40001623 | Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada |
| Q33819611 | Prevalence of systemic lupus erythematosus in South Korea: an administrative database study |
| Q37619974 | Prognostic factors in patients with systemic lupus erythematosus admitted to the intensive care unit. |
| Q36955326 | Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms |
| Q37629055 | Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies |
| Q33411232 | Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort |
| Q38076062 | Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population |
| Q44498317 | Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus |
| Q36991337 | Role of environment and sex differences in the development of autoimmune diseases: a roundtable meeting report |
| Q90285248 | SLE mortality remains disproportionately high, despite improvements over the last decade |
| Q26773130 | SLE: Another Autoimmune Disorder Influenced by Microbes and Diet? |
| Q36254076 | SLE: translating lessons from model systems to human disease |
| Q47253208 | Sample size considerations for superiority trials in systemic lupus erythematosus (SLE). |
| Q34535093 | Scleroderma epidemiology |
| Q30251721 | Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide |
| Q41680587 | Similarities and differences between pediatric and adult patients with systemic lupus erythematosus |
| Q36112590 | Social Determinants of Health, the Chronic Care Model, and Systemic Lupus Erythematosus |
| Q33738700 | Stress Intervention and Disease in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies (BLESS) Study |
| Q47889345 | Survival of patients with SLE admitted to an intensive care unit-a retrospective study |
| Q55933861 | Systemic lupus erythematosus |
| Q73730202 | Systemic lupus erythematosus |
| Q37754835 | Systemic lupus erythematosus and ethnicity: nature versus nurture or nature and nurture? |
| Q40440734 | Systemic lupus erythematosus and infections: a retrospective study in Saudis |
| Q34017775 | Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study |
| Q37921757 | Systemic lupus erythematosus in Hispanics |
| Q33363686 | Systemic lupus erythematosus in Pakistan |
| Q33357929 | Systemic lupus erythematosus in Tunisia. A multicentric study. About 295 cases |
| Q35597979 | Systemic lupus erythematosus. How to manage, when to refer |
| Q46686656 | Systemic lupus erythematosus: clinical manifestations, treatment and economics |
| Q36792304 | Systemic lupus erythematosus: current state of diagnosis and treatment |
| Q36673286 | Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. |
| Q98465712 | Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice |
| Q92703228 | The State of Lupus Clinical Trials: Minority Participation Needed |
| Q46216656 | The causes of death in Korean patients with systemic lupus erythematosus over 11 years |
| Q34212462 | The epidemiology of autoimmune diseases |
| Q37529071 | The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the Rochester Epidemiology Project |
| Q34109161 | The establishment and utility of a population-based registry to understand the epidemiology of systemic sclerosis |
| Q44723933 | The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort. |
| Q38936647 | The global burden of SLE: prevalence, health disparities and socioeconomic impact |
| Q30560762 | The impact of rural residency on the expression and outcome of systemic lupus erythematosus: data from a multiethnic Latin American cohort |
| Q36198947 | The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry |
| Q34808086 | The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. |
| Q40188124 | The national incidence and clinical picture of SLE in children in Australia - a report from the Australian Paediatric Surveillance Unit |
| Q38232471 | The need to define treatment goals for systemic lupus erythematosus |
| Q34680879 | The neuropathology and pathogenesis of systemic lupus erythematosus |
| Q35654884 | The prevalence and burden of systemic lupus erythematosus in a medicare population: retrospective analysis of medicare claims |
| Q50263868 | The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies |
| Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
| Q78814998 | Treatment of lupus nephritis |
| Q39297465 | Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010. |
| Q33621131 | Understanding the epidemiology and progression of systemic lupus erythematosus |
| Q35823414 | Update on the immunology, diagnosis and management of systemic lupus erythematosus |
| Q36575376 | Update on the treatment of lupus nephritis |
| Q37137321 | Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort |
| Q40882903 | Variations in the epidemiology of systemic lupus erythematosus in southern Sweden |
| Q53522204 | Vitamin D levels and cytokine profiles in patients with systemic lupus erythematosus. |
| Q84815168 | [Changes in mortality and morbidity in systemic lupus erythematosus] |
| Q50691910 | [Systemic lupus erythematosus in Martinique: an epidemiologic study]. |
Search more.